Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Bimekizumab
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Bimekizumab Bimzelx
®
(160 mg solution for injection in pre-filled pen or pre-filled syringe)
Musculoskeletal and joint diseases, Cytokine modulators, 10.01.03
RED
Bimekizumab Bimzelx
®
(160 mg solution for injection in pre-filled pen or pre-filled syringe)
Skin, Drugs affecting the immune response, 13.05.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Bimekizumab
Bimekizumab
Musculoskeletal System, Arthritis, Immunosuppressants Interleukin Inhibitors
Bimekizumab
Bimekizumab
Skin, Inflammatory Skin Conditions, Eczema And Psoriasis, Immunosuppressants Interleukin Inhibitors
Links found
NICE TA 723 Bimekizumab for treating moderate to severe plaque psoriasis
NICE TA1028: Bimekizumab for treating moderate to severe hidradenitis suppurativa (TERMINATED APPRAISAL)
NICE TA916: Bimekizumab for treating active psoriatic arthritis
NICE TA918: Bimekizumab for treating axial spondyloarthritis